In August 2025, EMJ conducted individual interviews with two European medical experts and a patient advocate who had survived infection in adolescence on the critical importance of timely immunisation against invasive meningococcal disease (IMD) in adolescents.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles


